Acetazolamide, residual congestion and clinical outcomes in acute heart failure - a prespecified analysis of the ADVOR trial [0.03%]
乙酰唑胺、急性心力衰竭代偿试验（ADVOR）中残余充血与临床结局的预设分析
Evelyne M Meekers,Pieter Martens,Jeroen Dauw et al.
Evelyne M Meekers et al.
Aims: Acetazolamide, an inhibitor of proximal tubular sodium reabsorption, improves decongestion in acute heart failure (AHF). The aim of the current subanalysis is to evaluate which factors influence decongestion success...
Circulating free fatty acid signatures discriminate myocardial infarction and systemic arterial hypertension [0.03%]
循环游离脂肪酸谱型可区分心肌梗死和系统性高血压
Simone Baldi,Luis Alejandro Constantino-Jonapa,Samuel Jaimez Alvarado et al.
Simone Baldi et al.
Background: Gut microbiome (GM) dysbiosis and altered circulating free fatty acid (FFA) profiles have been implicated in cardiovascular diseases (CVDs), including systemic arterial hypertension (SAH) and ST-segment elevat...
Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry [0.03%]
希腊选定医院急性冠脉综合征患者的流行病学及临床特征：CALLINICUS-Hellas注册研究
Demosthenes Panagiotakos,Donatos Tsamoulis,Vasileios Bouratzis et al.
Demosthenes Panagiotakos et al.
Background: the aim of this study is to evaluate features of acute coronary syndrome (ACS) patients, in Greece, using information from a nationwide registry, the Clinical events and Adherence to Lipid LowerINg therapy In ...
Patrizio Lancellotti
Patrizio Lancellotti
Cardiovascular medicine continues to move towards mechanistically informed, individualised patient care, supported by refined genetic, biochemical, and imaging tools. The studies featured in this issue of Acta Cardiologica span the genetic ...
Diagnostic value of ST-segment elevation in lead aVR exceeding V1 for identifying significant left main coronary artery disease in acute coronary syndrome [0.03%]
急性冠脉综合征中aVR导联ST段抬高超过V1导联的价值用于诊断左主干冠心病
Omur Kuru,Deniz Seleci
Omur Kuru
Background: Left main coronary artery (LMCA) disease carries high morbidity and mortality and requires early identification. Although ST-segment elevation in lead aVR has been associated with severe coronary artery diseas...
Inclisiran-based treatment strategy in very high cardiovascular risk patients with statin intolerance. Is the game worth the candle? [0.03%]
针对他汀类药物不耐受的极高心血管风险患者的inclisiran治疗策略。值得吗？
Beatrice Dal Pino,Francesco Sbrana
Beatrice Dal Pino
Evaluation of the feasibility and safety of cangrelor in out-of-hospital cardiac arrest undergoing percutaneous coronary intervention [0.03%]
坎格雷洛用于院外心脏骤停行经皮冠状动脉介入治疗患者的有效性和安全性评估研究
Manveer Singh,Fabien Picard,Alain Cariou et al.
Manveer Singh et al.
Background: In out-of-hospital cardiac arrest (OHCA) patients undergoing urgent percutaneous coronary intervention (PCI), the use of oral P2Y12 inhibitors is challenging due to delayed absorption. Cangrelor provides immed...
Six-year follow-up of stone heart syndrome from coronary artery dissection treated with PCI [0.03%]
PCI治疗冠状动脉夹层所致石心病6年随访
Li Wang,Haijuan Shangguan,Zheng Liu et al.
Li Wang et al.
Cinefluoroscopy: the Tom Thumb or the David of cardiovascular imaging for mechanical heart valves? [0.03%]
心血管影像中 cine 影像学技术是巨人的肩膀还是矮人的墙？机械心脏瓣膜的影像评价
Thierry Le Tourneau,Romain Capoulade,Patrice Guérin
Thierry Le Tourneau
Implementation opportunities for sodium-glucose Co-transporter-2 inhibitors in the Belgian heart failure landscape [0.03%]
钠葡萄糖协同转运蛋白2抑制剂在比利时心力衰竭领域的实施机会
Frederik H Verbrugge,Jean-Luc Vachiery,Wilfried Mullens
Frederik H Verbrugge